DK0420464T3 - 3-isoxazolonderivater, deres fremstilling af deres terapeutiske anvendelser - Google Patents

3-isoxazolonderivater, deres fremstilling af deres terapeutiske anvendelser

Info

Publication number
DK0420464T3
DK0420464T3 DK90310125.1T DK90310125T DK0420464T3 DK 0420464 T3 DK0420464 T3 DK 0420464T3 DK 90310125 T DK90310125 T DK 90310125T DK 0420464 T3 DK0420464 T3 DK 0420464T3
Authority
DK
Denmark
Prior art keywords
optionally substituted
alkyl
substituted phenyl
preparation
hydrogen
Prior art date
Application number
DK90310125.1T
Other languages
English (en)
Inventor
Mitsuo Nagano
Junichi Sakai
Nobuyoshi Iwata
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of DK0420464T3 publication Critical patent/DK0420464T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90310125.1T 1989-09-26 1990-09-17 3-isoxazolonderivater, deres fremstilling af deres terapeutiske anvendelser DK0420464T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24970089 1989-09-26
JP9697690 1990-04-12

Publications (1)

Publication Number Publication Date
DK0420464T3 true DK0420464T3 (da) 1994-11-07

Family

ID=26438116

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90310125.1T DK0420464T3 (da) 1989-09-26 1990-09-17 3-isoxazolonderivater, deres fremstilling af deres terapeutiske anvendelser

Country Status (8)

Country Link
EP (1) EP0420464B1 (da)
KR (1) KR910006251A (da)
AT (1) ATE108444T1 (da)
CA (1) CA2026177A1 (da)
DE (1) DE69010606T2 (da)
DK (1) DK0420464T3 (da)
ES (1) ES2060056T3 (da)
IE (1) IE69020B1 (da)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60267B1 (en) * 1986-12-26 1994-06-29 Sankyo Co Centrally-acting muscle relaxants

Also Published As

Publication number Publication date
CA2026177A1 (en) 1991-03-27
ES2060056T3 (es) 1994-11-16
DE69010606T2 (de) 1995-03-23
IE903445A1 (en) 1991-04-10
KR910006251A (ko) 1991-04-29
IE69020B1 (en) 1996-07-24
EP0420464A2 (en) 1991-04-03
EP0420464A3 (en) 1991-07-17
ATE108444T1 (de) 1994-07-15
DE69010606D1 (de) 1994-08-18
EP0420464B1 (en) 1994-07-13

Similar Documents

Publication Publication Date Title
NO873071L (no) Fremgangsmaate for fremstilling av amid-derivater.
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
HUP9902148A2 (hu) Új 2,3-diszubsztituált-4(3H)-kinazolinonok
DK0419397T3 (da) Substituerede urinsyreforbindelser, deres fremstilling og anvendelse
FR2800735B1 (fr) Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
PT98483A (pt) Processo para a preparacao de derivados de 3-aril-indol e 3-aril-indazol
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ES2110977T3 (es) Espiro-isoquinolein-pirrolidinas y analogos de las mismas, utiles como inhibidores de la aldosa-reductasa.
HUT65268A (en) Process for preparation of optically active 2-amino-1,2,3,4-tetrahydro-naphtaline derivatives
FI881104A0 (fi) Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi
FI833453A0 (fi) Terapeutiska medel
ES2109216T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica con actividad relajante muscular de accion central.
DK1083178T3 (da) Tetrahydroquinazolin-2,4-dioner og terapeutiske anvendelser deraf
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
ES2060056T3 (es) Derivados de 3-isoxazolonas, su preparacion y su utilizacion en terapeutica.
ES481207A1 (es) Un procedimiento para l preparacion de derivados de benzoci-cloheptapiridinas.
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
KR910700236A (ko) 치환된 3-아자비사이클로[3,1,1]헵탄, 이의 제조방법 및 이의 용도
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE67197T1 (de) Thiadiazinon-derivate.